Biotech From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream December 27, 2025
Biotech Eilean Therapeutics Advances ZE74-0282, a Highly Selective Inhibitor of Mutated JAK2 V617F, into First-in-Human Clinical Development December 18, 2025
Biotech Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout December 15, 2025
Biotech BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair December 10, 2025
Biotech GC Genome Study Identifies ‘Confounders’ Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy December 9, 2025
Biotech The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cystoscopy comparison December 8, 2025
Biotech Vivacta Bio Announces Promising First-in-Human Results for GT801, an In Vivo CAR-T Therapy, in Non-Hodgkin’s Lymphoma at the 2025 ASH Annual Meeting December 7, 2025